LONG TERM EFFECTS OF AN INTENSIVE TREATMENT USING RITUXIMAB IN SEVERE CASES OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

被引：0
|
作者：
Ruccatello, D.
Rossi, D.
Sciascia, S.
Alpa, M.
Naretto, C.
Baldovino, S.
Menegatti, E.
La Grotta, R.
Modena, V.
机构：
[1] Osped Torino Nord Emergenza San G Bosco, Ctr Ric Immunopatol & Documentaz Malattie Rare CM, Turin, Italy
[2] Univ Turin, Turin, Italy
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2011年 / 29卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
44
引用
收藏
页码：159 / 159
页数：1
相关论文
共 50 条
  • [31] LONG-TERM DATA ON RITUXIMAB AND BELIMUMAB THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Nikishina, N.
    Mesnyankina, A.
    Aseeva, E.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S456 - S456
  • [32] Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus
    Catapano, Fausta
    Chaudhry, Afzal N.
    Jones, Rachel B.
    Smith, Kenneth G. C.
    Jayne, David W.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (11) : 3586 - 3592
  • [33] Cyclophosphamide and Rituximab Combination Treatment For Severe Systemic Lupus erythematosus is Effective and Well Tolerated
    Shahzad, Ali
    Jafri, Farheen
    Rizvi, Bisharah
    Zhao, Xiongce
    Waldman, Meryl
    Hasni, Sarfaraz A.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S662 - S662
  • [34] LONG-TERM RESULTS OF THERAPY WITH RITUXIMAB AND BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Issayeva, B.
    Mesnyankina, A.
    Aseeva, E.
    Nikishina, N.
    Issayeva, S.
    Saparbayeva, M.
    Bizhanova, M.
    Amanzholova, A.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S181 - S181
  • [35] Effect of Rituximab on Long-term Damage Acquisition in Patients with Systemic Lupus Erythematosus
    Brito, Amanda
    de Almeida, Teresa Moitinho
    Miranda, Sofia
    Baie, Miriam Barreto
    Calado, Daniel
    Isenberg, David
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3147 - 3149
  • [36] Rituximab use in systemic lupus erythematosus (SLE): a 2 years retrospective analysis
    Bidon, Doriane
    Metz, Carole
    Benameur, Neila
    Tilleul, Patrick
    Amoura, Zahir
    Junot, Helga
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 272 - 272
  • [37] Long-term follow-up of patients with refractory systemic lupus erythematosus during rituximab treatment
    Tsanyan, M. E.
    Soloviev, S. K.
    Torgashina, A. V.
    Aleksandrova, E. N.
    Radenska-Lopovok, S. G.
    Nikolaeva, E. V.
    Khrennikov, Ya. B.
    Nasonov, E. L.
    TERAPEVTICHESKII ARKHIV, 2014, 86 (05) : 40 - 49
  • [38] Treatment with rituximab for thrombocytopenia due to systemic lupus erythematosus
    Calderon Saldierna, Rosa Elena
    Ramos Sanchez, Maria Azucena
    Mejia Holguin, Yadhira
    Aranda Baca, Laura Elena
    Sauza del Pozo, Maria Josefina
    Becerra Marquez, Ariana Maia
    REUMATOLOGIA CLINICA, 2010, 6 (02): : 82 - 85
  • [39] Effect of Rituximab (RTX) Treatment on the Immune System in Patients with Systemic Lupus Erythematosus (SLE) in the EXPLORER Trial
    Tew, Gaik
    Rabbee, Nusrat
    Monroe, John
    Behrens, Tim
    Brunetta, Paul
    Keir, Mary
    CLINICAL IMMUNOLOGY, 2009, 131 : S29 - S29
  • [40] Identification of Clinical and Serological Predictive Factors of Response to Rituximab Treatment in Systemic LUPUS Erythematosus (SLE) Patients
    Sanchez-Perez, Hiurma
    Isenberg, David A.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345